Golden Virtue Res (FLNTF) 0.1800 $FLNTF Reliq Health

New Post Public Reply Private Reply Replies (0) Message Board

Sep 15, 2016 at 1:03 AM

Golden Virtue Res (FLNTF) 0.1800 $FLNTF

Reliq Health Announces US$1.22M Contract with NextGen Partners in San Antonio, TX
GlobeNewswire - Wed May 11, 6:04PM CDT
Reliq Health Technologies Inc. (TSXV:RHT) (OTCQB:FLNTF) ("Reliq" or the "Company"

, a technology company focused on developing innovative mobile health ("mHealth"

and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has signed a contract with NextGen Partners LLC of San Antonio, TX (NextGenPartnersLLC.com, info@nextgenpartnersllc.com) valued at $1.22 Million US Dollars. The contract provides NextGen with professional services and a limited license to Reliq's proprietary iUGO Health platform (formerly known as CareKit Health), specifically for the development of a consumer focused mobile health app ("Mindful Health" App) that will be provided to the residents of San Antonio, TX.
RHT.VN: 0.085 (+0.005)

Moseda Provides Corporate Update
Marketwire Canada - Mon May 09, 4:05PM CDT
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 9, 2016) - Moseda Technologies Inc. (TSX VENTURE:MSD)(OTCQB:FLNTF) ("Moseda" or the "Company"

, a technology company focused on developing progressive mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is excited to announce that further to its news release announced May 4, 2016 the Company has received TSX Venture Exchange approval to change its name (the "Name Change"

to Reliq Health Technologies Inc.
MSD.VN: 0.215 (-0.005)

Moseda Announces Board Resignation
Marketwired - Mon May 02, 8:01AM CDT
Moseda Technologies Inc. (TSX VENTURE: MSD)(OTCQB: FLNTF) ("Moseda" or the "Company"

, a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, announces that Mr. Nicholas Murray has resigned from the Company's Board of Directors effective immediately. The balance and release schedule of Mr. Murray's escrowed shares in the Company will remain unchanged. For the full escrow release schedule please reference the Filing Statement on SEDAR.
MSD.VN: 0.215 (-0.005)

Moseda to Present at The MicroCap Conference
Marketwired - Thu Apr 07, 9:00AM CDT
Moseda Technologies Inc. (TSX VENTURE: MSD)(OTCQB: FLNTF) ("Moseda" or the "Company"

, a technology company focused on developing progressive mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is excited to announce that it will be presenting to investors on Monday, April 11 at 3:00PM EST at the Hilton Toronto. Moseda will also be available for one-on-one meetings with investors throughout the conference.
MSD.VN: 0.215 (-0.005)

Moseda Announces Acquisition of CareKit Health
Marketwired - Tue Feb 09, 7:03AM CST
Moseda Technologies Inc. (TSX VENTURE: MSD) ("Moseda" or the "Company"

, a technology company focused on developing progressive mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has acquired CareKit Health Corporation ("CareKit"

, a commercial stage healthcare technology company that has built a comprehensive hardware and software platform that allows complex patients to receive high quality care in the home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. CareKit's platform for care coordination and home healthcare integrates wearables, sensors, a proprietary voice technology hub and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. For more information please visit: www.carekithealth.com.
MSD.VN: 0.215 (-0.005)

Moseda Announces Appointment of Experienced Healthcare Technology Executive
Marketwired - Mon Jan 18, 6:00AM CST
Moseda Technologies Inc. (TSX VENTURE: MSD) ("Moseda" or the "Company"

, a technology company focused on developing progressive mobile health (mHealth) and telemedicine solutions for institutional and home healthcare, is pleased to announce that it has appointed industry expert Dr. Lisa Crossley, PhD., P.Eng. as CEO and Director and Mr. Sameet Kanade as President and Chairman of the Board as the Company aims to ramp up its client acquisition strategy.
MSD.VN: 0.215 (-0.005)

Moseda Announces Global Partnership With Leading Bluetooth Beacon Manufacturer
Marketwired - Tue Dec 15, 10:31AM CST
Moseda Technologies Inc. (TSX VENTURE: MSD) (OTCQB: FLNTF) ("Moseda" or the "Company"

, a technology company focused on developing progressive mobile health (mHealth) and telemedicine solutions for institutional and home healthcare, is pleased to announce that it has selected Kontakt.io as a hardware partner.
MSD.VN: 0.215 (-0.005)

Moseda Technologies Announces $250,000 Repeat Sale to Health Care Client
Marketwire Canada - Tue Dec 01, 2:10AM CST
Moseda Technologies Inc. (TSX VENTURE:MSD)(OTCQB:FLNTF) ("Moseda" or the "Company"

, a technology company focused on developing progressive mobile health (the "mHealth"

and telemedicine solutions for institutional and home healthcare, is pleased to announce that it has received a second purchase ordering totalling over CAD $250,000 from an existing client for software and hardware. The client is servicing a company in the home care market with over 50,000 patients.
MSD.VN: 0.215 (-0.005)

Moseda Technologies Announces Pilot Project With a Seniors' Housing, Hospitality and Health Services Company
Marketwired - Tue Nov 17, 3:01AM CST
Moseda Technologies Inc. (TSX VENTURE: MSD)(OTCQB: FLNTF) ("Moseda" or the "Company"

, a technology company focused on developing progressive mobile health (the "mHealth"

and telemedicine solutions for institutional and home healthcare, is pleased to announce that it has launched a pilot project with a Western Canadian based seniors' housing company (the "Client"

.
MSD.VN: 0.215 (-0.005)

Moseda Technologies Commences Trading on the OTCQB Marketplace
Marketwired - Thu Nov 12, 3:01AM CST
Moseda Technologies Inc. (TSX VENTURE: MSD) ("Moseda" or the "Company"

, a technology company focused on developing progressive mobile health (mHealth) and telemedicine solutions for institutional and home healthcare, is pleased to announce that the effective November 12 the Company has been listed for trading on the OTCQB Marketplace in the United States under the symbol "FLNTF."
MSD.VN: 0.215 (-0.005)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Windward Bio Surges 68% in Nasdaq Debut

By Ryan Hughes Updated Nov 13, 2026 Category News Views 243

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Retirement Dreams Dashed: 61% Withdraw Early

By Olivia Taylor Updated Nov 14, 2026 Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

SmallRig Boosts Art-Driven Innovation in AI Era

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

El Pollo Loco Faces Class Action Over Wage Practices

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....